The discovery of vemurafenib for the treatment of BRAF-mutated metastatic melanoma
Author:
Funder
National Cancer Institute
University of Michigan Cancer Center Support Grant
University of Michigan Medical School
Publisher
Informa UK Limited
Subject
Drug Discovery
Link
http://www.tandfonline.com/doi/pdf/10.1080/17460441.2016.1201057
Reference60 articles.
1. Metastatic melanoma treatment: Combining old and new therapies
2. Final Version of 2009 AJCC Melanoma Staging and Classification
3. Meta-Analysis of Phase II Cooperative Group Trials in Metastatic Stage IV Melanoma to Determine Progression-Free and Overall Survival Benchmarks for Future Phase II Trials
4. Mutations of the BRAF gene in human cancer
Cited by 127 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Exploring the Therapeutic Potential of Ginkgo biloba Polyphenols in Targeting Biomarkers of Colorectal Cancer: An In-silico Evaluation;Current Drug Discovery Technologies;2024-11
2. Genomic landscape of head and neck cancer in Asia: A comprehensive meta-analysis of 1016 samples;Oral Oncology Reports;2024-09
3. Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in Melanoma;Cancers;2024-08-22
4. Molecular Susceptibility and Treatment Challenges in Melanoma;Cells;2024-08-20
5. Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanoma;2024-08-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3